Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications
Crossref DOI link: https://doi.org/10.1186/s12888-017-1213-6
Published Online: 2017-02-13
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Llorca, Pierre-Michel
Lançon, Christophe
Hartry, Ann
Brown, T. Michelle
DiBenedetti, Dana B.
Kamat, Siddhesh A.
François, Clément
Funding for this research was provided by:
Otsuka America Pharmaceutical
Lundbeck LLC
